Human papillomavirus in cervical intraepithelial neoplasia in Bangladesh

Bangladesh Journal of Obstetrics and Gynecology

Volumn 20, Issue 1, 2005, Pages 13-18

  Ashrafunnessa, ^a   Kahtun, S ^b   Chowdhury, T A ^c   Shamsuddin, L ^a   Islam, M N ^a   Hassan, M S ^c   Ali, S ^d  

^a BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

^b Bangladesh International Medical College   (Bangladesh)

^c Bangladesh Institute of Research and Rehabilitation in Diabetes Endocrine and Metabolic Disorders   (Bangladesh)

^d DHAKA MEDICAL COLLEGE   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 51049096785     PISSN: 10184287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. European Journal of cancer 2001;37:S4-S66.
2. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J and Powell J (eds.). Comparability and quality of data. In: Parkin DM et al ed. Cancer incidence in five countries (Vol VI). IARC Scientific Publication, Lyon. France: IARG Press, 1992; 45-173.
3. Akhter PS, Uddin MM, Sharma SK. Patterns of malignant neoplasm- a three years study. Bangladesh Medical Journal 1998;27(2):29-32.
4. Kulkarni PV, Jaiswal SS, Rathod SB, Khalique A, Kulkarni RR. Profile of malignancies at medical college, Ambajogai - (15 years retrospective study). Indian Journal of Cancer 1996;33:31-36.
5. Banerjee AK, Bhattacharya N, Chowdhury MK, Chattopadhyay R, Sengupta J. Incidence of malignancy in Bankura. J Indian med assoc 1994;92(12):400-402.
6. Sharma RG, Ajmera R, Saxena O. Cancer profile in Eastern Rajasthan. Indian Journal of Cancer 1994;31:160-173.
7. Huq SF. Common cancers of Bangladesh: their trends through last three decades. Bangladesh medical journal 1988;17(3):55-63.
8. Zur Hausen H. Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol 1977;78:1-30.
9. Bosch FX, Manos MM, Murioz N, Sherman M, Jansen AM, Peto J Schiffman MH, Moreno V, Kurman R, Shah KV. Prevalence of Human papillomavirus in cervical caner: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
10. Cuzick J, Terry G, Ho L, Hollingworth T and Anderson M. Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer 994;69:167-171.
11. Lorincz AT. Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ.Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79(3):328-337.
12. Reeves WC, Brinton L A, Garcia M, Brenes MM, Herrero R, Gaitan E, Tenorio F, DE Brinton RC and Rawls WE. Human papillomavirus infection and cervical cancer in Latin America. N Engl J Med 1989;320(22):1437-1441.
13. Ho GYF, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R, Romney S. Persistent genital Human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1367-1371.
14. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, Kurman RJ and Manos MM. Persistence of type-specific Human papillomavirus infection among cytologically normal women. The Journal of Infectious Diseases 1994;169:235-240.
15. Walboomers JMM, Jacobs MV, Manos MM, Borch FX, Kummer A, Shah KV, Snijders PJF, Peto J, Meijer CJLM and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189: 12-19.
16. Cuzick J. Human papillomavirus testing for primary cervical cancer screening. JAMA 2000; 283(1):108-109.
17. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, Mcintosh KM, Pawlick GF, Hiatt RA. Identifying women with cervical neoplasia using Human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999;281(17):1605-1610.
18. Liaw KL, Hsing AW, Chen CJ, Schiffman MH, Zhang TY, Hsieh CY, Greer CE, You SL, Huang TW, Wu TC, O'Leary TJ, Seidman JD, Blot WJ, Meinert CL, and Manos MM. Human papillomavirus and cervical neoplasia: A case-control study in taiwan. Int J Cancer 1995;62: 565-571.
19. Ferrera A, Velema JP, Figueroa M, Bulnes R, Toro LA, Claros JM, Barahona OD and Melchers WJG. Human papillomavirus infection, cervical dysplasia and invasive cervical cancer in Honduras: a case-control study. Int J Cancer 1999;82:799-803.
20. Das BC, Murthy NS, Sharma JK, Singh V, Sehgal A, Gopalkrishna V, Das DK and Luthra UK. Human papillomavirus and cervical cancer in Indian women. The Lancet 1989:1271.
21. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, Scott DR, Sherman ME, Kurman RJ, Wacholder S, Stanton CK, Manos MM. Epidemiologic evidence showing that Human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-964.
22. Olsen AO, Gjoen K, Sauer T, Orstavik I, Ness O, Kierulf K, Sponland G and Magnus P. Human papillomavirus and cervical intraepithelial neoplasia grade II-III: a population-based case-control study. Int J Cancer 1995;61:312-315.
23. Kjaer SK, Van Den Brule AJC, Bock JE, Poll PA, Engholm G, Sherman ME, Walboomers JMM, and Meijer CJLM. Human papillomavirus-the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 1996;65: 601-606.
24. Kjellberg L, Wiklund F, Sjoberg I, Wadell G, Angstrom T, Dillner J and Mahlck CG. A population-based study of Human papillomavirus deoxyribonucleic acid testing for predicting cervical intraepithelial neoplasia. Am J Obstet Gynecol 1998;179(6):1497-1502.
25. Lakshmi N, Kumar AG, Anand T, Reddy BK. Sero-prevalence of herpes simplex virus type-2 among cancer cervix patients. Indian J Cancer 1993;30(4):189-191.
26. Luthra UK, Probhakar AK, Seth P, Agarwal SS, Murthy NS, Bhatnagar P, Das DK and Sharma BK. Natural history of precancerous and early cancerous lesions of the uterine cervix. Acta Cytologica 1987;31(3):226-234
27. Hakama M, Lehtinen M, Knekt P, Aromaa A, Leinikki P, Miettinen A, Paavonen J, Peto R and Teppo L. Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up. Am J Epidemiol 1993;137: 166-170.
28. Prakash SS, Reeves WC, Sisson GR, Brenes M, Godoy J, Bacchetti S, de Britton RC and Rawls WE. Herpes simplex virus type 2 and human papillomavirus type 16 in cervicitis, dysplasia and invasive cervical carcinoma. Int J Cancer 1985;35:51-57.
29. Kjaer SK, Engholm G, Teisen C, Haugaard BJ, Lynge E, Christensen RB, Moller KA, Jensen H, Poll P, Vestergaard BF, DE Villiers EM, and Jensen OM. Risk factors for cervical Human papillomavirus and herpes simplex virus infections in Greenland and Denmark: A population - based study. Am J Epidemiol 1990;131(4):669-682.
30. Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, Miller S, Clayton L, Farhat S, Broering J, Darragh T and Palafsky J. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001;285 (23):2995-3002.
31. Falls RK. Spontaneous resolution rate of grade 1 cervical intraepithelial neoplasia in a private practice population. Am J Obstet Gynecol 1999; 181(2):278-282.